1. Home
  2. KHC vs TEVA Comparison

KHC vs TEVA Comparison

Compare KHC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$23.15

Market Cap

27.9B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$33.05

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KHC
TEVA
Founded
1869
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KHC
TEVA
Price
$23.15
$33.05
Analyst Decision
Hold
Strong Buy
Analyst Count
18
9
Target Price
$26.89
$34.67
AVG Volume (30 Days)
16.2M
10.5M
Earning Date
02-11-2026
01-28-2026
Dividend Yield
6.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.21
Revenue
$25,164,000,000.00
$17,258,000,000.00
Revenue This Year
N/A
$0.63
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$27.33
Revenue Growth
N/A
4.32
52 Week Low
$21.99
$12.47
52 Week High
$33.35
$33.44

Technical Indicators

Market Signals
Indicator
KHC
TEVA
Relative Strength Index (RSI) 42.85 69.86
Support Level $22.99 $30.94
Resistance Level $23.91 $32.86
Average True Range (ATR) 0.55 0.94
MACD 0.00 -0.07
Stochastic Oscillator 42.28 91.59

Price Performance

Historical Comparison
KHC
TEVA

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. However, the firm now intends to split its global sauces arm from its North American grocery segment in the second half of 2026. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for nearly 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: